Episode Details

Back to Episodes
Aurora Buys UK Cannabis Pharmacy, Spice-Laced Gummies, Germany's Cannabis Boom & 37% Higher Stroke Risk | Cannabis News Ep. 224

Aurora Buys UK Cannabis Pharmacy, Spice-Laced Gummies, Germany's Cannabis Boom & 37% Higher Stroke Risk | Cannabis News Ep. 224

Episode 735 Published 3 weeks ago
Description

This week on High on Home Grown, we have another packed episode of cannabis news from the UK, Europe and beyond, covering the rapidly developing medical cannabis market, dangerous illicit edibles, legalisation in Germany and the latest research into cannabis and health.

Macky: Aurora Buys UK Pharmacy and Import Licence for £2.1m, Securing 'Direct Route' to Patients 

Smee: Cannabis gummies sold on social media are laced with spice, scientists warn | The Independent 

Billy:  Germany bec@ft omes Europe’s largest regulated cannabis market 

Margaret: Cannabis use linked to 37% higher stroke risk in massive study | ScienceDaily

This week we discuss Aurora's move to buy its own UK pharmacy and licensed importer, and what greater control over the supply chain could mean for Britain's rapidly expanding medical cannabis market. We also examine the disturbing discovery of synthetic Spice in illicit cannabis gummies, highlighting the huge difference between regulated products and mystery edibles being sold through social media.

Billy takes us over to Germany, where the country's cannabis reforms have created Europe's largest regulated market, while Dr. Margaret brings us the latest large-scale research examining potential cardiovascular risks associated with cannabis use. And, of course, we have to explain John's mysterious absence from the show this week...

Another episode packed with cannabis news, science, business, regulation and plenty for the panel to argue about.

🌐 Website: https://highonhomegrown.com
💬 Discord: https://discord.gg/sqYGkF4xyQ
📺 YouTube: https://www.youtube.com/highonhomegrown

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us